AI-generated summary
In streptozotocin-induced diabetic rats, the authors tested 670 nm near-infrared light therapy on liver antioxidant markers. They report no antioxidant benefit in chronic diabetes, but after 18 days of daily treatment in acute diabetes, several antioxidant enzyme activities were normalized or increased. The authors suggest the effect may be partial.
- Who or what was studied
- Male Wistar rats made diabetic with streptozotocin, studied in acute and chronic diabetes models
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study was conducted in rats, and the abstract does not report the number of animals per group or how the results were analyzed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Oxidative stress, Photobiomodulation, Wound healing, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.